No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
379 |
4. Check minimum number of eventsNone |
379 |
5. Include endpointsNone |
379 |
6. Filter based on genotype QC (FinnGen only) |
347 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Similar endpoints
↥List of similar endpoints to
Arnold-Chiari syndrome
based on the number of shared cases.
Similar with more cases:
- Other congenital malformations of nervous system
- Congenital malformations of the nervous system
- Congenital malformations, deformations and chromosomal abnormalities
- Congenital malformations, deformations and chromosomal abnormalities, including avohilmo
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 347 | 286 | 61 |
| Unadjusted period prevalence (%) | 0.09 | 0.10 | 0.03 |
| Median age at first event (years) | 32.93 | 33.25 | 31.43 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 358
- Matched controls
- 3580
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q07.0
ICD-10 Finland
Arnold-Chiari syndrome
+∞
307.7
357
*
ABE50
NOMESCO Finland
Occipitocervical decompression
+∞
112.6
102
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
11.8
76.4
88
96
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
7.2
59.9
111
211
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
14.1
48.8
47
38
R51.80
ICD-10 Finland
Headache
4.9
47.7
166
541
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
243.5
42.9
43
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.9
41.4
89
191
N03AX12
ATC
[U] gabapentin; oral
4.3
28.2
87
247
AA1AD
NOMESCO Finland
CT of head and brain
3.8
27.9
112
384
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.2
27.7
64
144
R42
ICD-10 Finland
Dizziness and giddiness
3.8
27.6
113
392
R20.2
ICD-10 Finland
Paraesthesia of skin
4.6
23.4
63
160
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
19.6
22.7
34
19
G44.2
ICD-10 Finland
Tension-type headache
3.4
22.6
104
384
N06AX21
ATC
duloxetine; oral
3.6
19.1
74
243
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
17.4
18.7
29
18
Z01.8
ICD-10 Finland
Other specified special examinations
2.9
18.2
110
470
R51
ICD-10 Finland
Headache
4.1
17.7
53
145
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.3
17.2
75
264
N03AX16
ATC
[U] pregabalin
3.1
17.1
87
336
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
21.3
16.7
24
12
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.5
15.3
58
186
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.1
14.5
70
261
N02BF01
ATC
gabapentin; oral
3.5
14.4
54
172
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
14.2
101
462
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.3
13.8
38
97
N02AX02
ATC
tramadol; systemic, rectal
2.4
13.5
142
777
A01
ICPC
Pain general/multiple sites
3.2
12.8
56
196
TAB00
NOMESCO Finland
Lumbar puncture
4.1
12.2
35
92
L28
ICPC
Limited function/disability (L)
2.9
11.6
63
249
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.8
11.2
65
266
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
11.1
175
1108
A02BC02
ATC
pantoprazole; systemic
2.1
10.6
220
1535
L01
ICPC
Neck symptom/complaint
2.4
10.5
90
444
SPAT1310
SPAT
Counselling related to known health issue
2.1
10.0
141
849
G47.3
ICD-10 Finland
Sleep apnoea
2.5
9.8
71
323
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
56.6
9.7
11
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
9.3
75
358
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
9.3
81
401
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
9.2
103
564
M54.5
ICD-10 Finland
Low back pain
2.0
9.1
148
930
R52.2
ICD-10 Finland
Other chronic pain
4.5
9.0
22
51
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.1
9.0
40
141
M03BX01
ATC
baclofen; systemic
8.3
9.0
19
24
N06AX16
ATC
venlafaxine; oral
2.3
8.8
73
352
G43.3
ICD-10 Finland
Complicated migraine
4.4
8.8
22
52
XKD00
NOMESCO Finland
Uroflowmetry
3.4
8.6
32
101
N03AX11
ATC
topiramate; oral
4.2
8.5
23
58
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.5
8.4
29
87
N03AE01
ATC
clonazepam; systemic
3.8
8.2
25
69
M03BX02
ATC
tizanidine; oral
1.9
8.2
217
1592
UKC02
NOMESCO Finland
Cystoscopy
3.1
8.1
35
121
M54.3
ICD-10 Finland
Sciatica
4.0
8.1
23
60
SPAT1153
SPAT
Removal of sutures
2.1
8.0
94
521
A02BC05
ATC
esomeprazole; systemic
2.0
8.0
127
786
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.0
7.9
35
123
WX882
NOMESCO Finland
High dependency care
4.0
7.8
22
57
N01
ICPC
Headache
2.0
7.8
98
558
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.7
7.7
18
40
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
7.7
54
241
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
18.9
7.6
11
6
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.3
7.6
20
49
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.3
7.6
29
93
SPAT1263
SPAT
Sampling
1.9
7.6
168
1153
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
7.6
54
243
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
6.2
7.5
19
32
M35.7
ICD-10 Finland
Hypermobility syndrome
6.2
7.5
19
32
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
7.9
7.5
16
21
R52.9
ICD-10 Finland
Pain, unspecified
2.5
7.4
52
232
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
9.7
7.3
14
15
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.8
7.3
22
60
N99
ICPC
Neurological disease other
16.1
7.3
11
7
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
7.6
7.3
16
22
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
3.9
7.2
21
56
G44.8
ICD-10 Finland
Other specified headache syndromes
6.3
7.2
18
30
M79.6
ICD-10 Finland
Pain in limb
1.8
7.1
166
1151
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.0
7.1
31
108
H02AB06
ATC
prednisolone; systemic
1.8
7.1
153
1036
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.0
7.1
89
504
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
7.0
42
174
R96
ICPC
Asthma
2.6
6.9
42
175
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
3.9
6.9
20
53
M54
ICD-10 Finland
Dorsalgia
2.2
6.9
62
309
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
3.1
6.8
28
94
A02BC01
ATC
omeprazole; systemic
2.0
6.8
94
550
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
6.8
78
427
WX402
NOMESCO Finland
General anaesthesia
2.0
6.8
95
558
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
40.8
6.8
8
*
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
17.1
6.8
10
6
ZXE20
NOMESCO Finland
More than three and less than five hours
2.5
6.8
45
196
SPAT1301
SPAT
No procedures
1.9
6.8
119
754
S06.0
ICD-10 Finland
Concussion
2.3
6.7
53
249
N03AX09
ATC
lamotrigine; oral
2.8
6.7
35
135
N06AA09
ATC
amitriptyline; systemic
3.0
6.6
29
101
C09CA06
ATC
candesartan; oral
2.0
6.6
76
417
R03AC02
ATC
salbutamol; inhalant
1.8
6.5
222
1706
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
6.5
81
456
N02BE01
ATC
paracetamol; systemic, rectal
2.2
6.5
306
2611
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
71.1
6.4
7
*
A04
ICPC
Weakness/tiredness general
2.0
6.4
79
443
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.0
6.3
18
47
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.3
125
818
Q07.8
ICD-10 Finland
Other specified congenital malformations of nervous system
+∞
6.3
6
*
AA1BG, ,
SPAT
5.5
6.2
17
32
SPAT1216
SPAT
Assessment of functional ability
2.5
6.1
41
179
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
10.3
6.1
11
11
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
6.1
33
130
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
216
1270
2.77
19.43
9.6
6.3
1.21
1.22
mmol/l
0.54
194
1121
197
1144
2.61
17.57
12.8
6.1
1.21
1.22
mmol/l
1.19
184
1081
60
194
3.51
15.68
16.4
8.6
0.01
0.86
mmol/l
0.53
43
154
36
81
4.83
15.32
2.3
2.3
74.36
8.64
e6/l
0.99
28
56
36
83
4.71
14.88
2.3
2.3
138.39
135.68
e6/l
0.01
28
62
242
1649
2.44
13.94
9.3
4.6
5.96
6.21
mmol/l
1.76
231
1489
131
687
2.43
13.77
2.3
2.1
269.99
242.58
u/l
0.07
125
664
347
2942
6.84
11.89
20.3
11.3
3.92
3.90
mmol/l
0.95
341
2861
24
28
9.10
11.72
2.9
1.6
—
—
—
0
0
18
12
15.72
11.43
1.1
1.5
—
—
—
0
0
346
2947
6.19
11.32
20.5
11.1
139.77
139.56
mmol/l
1.34
340
2877
278
2117
2.40
10.94
7.2
6.9
73.74
79.09
u/l
1.33
267
2007
135
779
2.18
10.83
3.3
3.0
17.06
22.75
ng/l
0.32
65
373
288
2240
2.46
10.59
4.5
4.0
8.11
8.76
mm/h
0.50
276
2114
16
11
15.15
10.09
1.4
1.9
—
—
—
0
0
317
2620
2.83
9.53
5.9
4.6
14.42
14.37
pmol/l
0.14
300
2443
88
448
2.28
9.44
1.6
1.5
112162614.86
433.05
pmol/l
0.49
74
404
161
1034
2.01
9.40
5.3
4.9
38.21
37.52
g/l
1.25
148
990
72
345
2.36
8.84
5.0
2.7
27.98
29.36
s
1.50
67
337
134
824
2.00
8.69
3.5
2.5
49.98
58.50
u/l
2.17
124
774
54
229
2.60
8.60
25.8
8.1
23.83
25.12
mmol/l
1.76
54
229
340
2969
3.89
8.32
6.9
5.4
1.59
1.79
mu/l
3.74
327
2835
58
263
2.44
8.02
2.3
2.3
27.51
13.51
au/ml
—
8
27
161
1082
1.89
7.83
2.3
1.8
97.91
98.69
pmol/l
0.07
99
565
196
1403
1.88
7.82
6.6
5.7
10.39
10.82
umol/l
0.12
186
1323
85
462
2.10
7.60
4.4
3.5
975.89
742.86
ng/l
0.22
69
370
128
822
1.87
7.01
2.3
2.3
2.78
2.57
mg/l
0.60
110
718
67
344
2.17
6.89
2.0
2.0
374.49
394.85
nmol/l
0.34
61
325
50
227
2.40
6.87
4.9
4.7
—
—
—
0
0
298
2524
2.08
6.33
5.0
4.5
36.54
36.83
mmol/mol
0.26
281
2412
43
192
2.41
6.12
12.2
5.2
0.83
1.01
mmol/l
0.20
27
136
105
664
1.82
5.88
2.8
2.0
0.85
1.06
mg/l
0.40
72
478
133
908
1.74
5.71
2.6
2.7
2.36
2.36
mmol/l
0.03
124
850
60
321
2.04
5.50
1.7
1.5
1053.33
1091.37
nmol/l
0.14
50
253
240
1935
1.73
5.49
3.8
3.3
70.93
61.20
ug/l
0.55
231
1844
139
970
1.71
5.47
4.5
3.0
—
—
—
0
0
229
1827
1.70
5.41
9.8
8.8
3.75
3.93
e9/l
0.69
203
1581
187
1419
1.67
5.31
3.3
2.6
69.90
71.81
nmol/l
0.47
176
1329
67
378
1.95
5.29
2.7
2.3
2.60
2.45
g/l
1.50
61
349
28
109
2.70
5.27
2.8
3.3
99.74
126.83
ng/l
0.25
23
99
343
3139
3.21
5.16
18.2
11.4
15.28
19.77
mg/l
3.11
304
2473
143
1024
1.66
5.00
4.2
3.1
30.52
27.75
u/l
0.25
136
974
13
25
5.35
4.81
1.2
1.4
1.29
0.53
ratio
—
8
11
103
682
1.72
4.81
1.8
1.5
18.63
20.57
nmol/l
0.69
91
597
114
779
1.68
4.72
2.9
2.0
—
—
—
0
0
94
611
1.73
4.67
2.1
2.8
296.81
305.83
umol/l
0.38
83
556
28
117
2.51
4.60
6.1
3.8
0.54
0.63
%
0.81
28
117
58
327
1.92
4.57
1.4
1.6
20.39
19.07
iu/l
0.12
45
270
63
367
1.87
4.50
2.0
1.9
—
—
—
0
0
305
2693
1.90
4.49
4.4
3.7
5.56
5.58
mmol/l
0.08
287
2529
18
60
3.11
4.46
2.1
1.6
—
—
—
0
0
15
37
4.19
4.46
1.1
1.1
—
—
—
0
0
13
28
4.78
4.41
1.1
1.1
—
—
—
0
0
193
1521
1.58
4.39
3.2
2.7
—
—
estimate
—
0
0
19
67
2.94
4.29
2.0
1.6
1067.33
153.52
ug/l
0.81
12
60
52
289
1.94
4.27
9.5
5.0
1.76
1.45
mmol/l
0.42
47
234
258
2198
1.62
4.05
4.2
3.1
29.40
32.41
u/l
0.60
249
2115
147
1105
1.56
4.00
1.5
1.5
0.64
2.17
u/ml
2.17
42
291
14
38
3.79
3.84
1.0
1.1
—
—
—
0
0
33
163
2.13
3.74
3.6
3.7
1.23
1.22
mmol/l
0.61
27
140
108
766
1.59
3.74
4.6
3.0
1.02
1.02
kg/l
0.01
59
496
96
663
1.61
3.71
1.4
1.3
13.06
21.98
iu/ml
1.69
27
182
162
1263
1.52
3.64
5.1
3.0
0.08
0.02
estimate
0.36
37
310
122
906
1.53
3.40
5.1
3.2
0.02
0.00
estimate
0.40
49
353
300
2695
1.70
3.39
13.2
9.8
99.45
96.17
ml/min/173m2
2.10
278
2397
45
259
1.84
3.34
1.8
1.8
—
—
—
0
0
38
208
1.93
3.28
10.8
5.4
24.57
23.90
mmol/l
1.44
38
208
56
348
1.72
3.22
4.4
3.2
5.18
7.04
umol/l
0.66
50
288
57
358
1.70
3.15
1.3
1.3
121.84
147.36
u/ml
0.29
22
143
43
251
1.81
3.06
1.8
1.8
—
—
—
0
0
206
1727
1.45
3.02
5.2
3.3
0.00
3.89
estimate
0.50
51
362
41
239
1.81
2.93
2.3
3.2
0.21
0.23
g/l
0.49
35
229
65
432
1.62
2.90
2.1
2.2
2.41
2.41
mmol/l
0.03
60
389
10
27
3.78
2.90
1.8
3.0
—
—
—
0
0
206
1741
1.43
2.80
5.4
3.4
0.00
0.00
estimate
-0.00
50
342
9
23
3.99
2.79
7.1
4.6
1.82
1.86
ug/l
—
9
23
67
454
1.59
2.76
2.0
1.7
1.33
1.35
%
0.12
60
404
47
295
1.68
2.62
2.4
2.4
25.27
31.43
u/l
0.94
41
236
147
1185
1.41
2.54
2.2
1.9
—
—
—
0
0
201
1711
1.40
2.51
5.3
3.3
0.00
0.00
estimate
0.50
47
365
7
16
4.44
2.48
1.0
1.3
—
—
—
0
0
66
457
1.54
2.47
4.0
2.8
5.18
3.47
e6/l
0.55
33
203
15
64
2.40
2.42
2.2
1.2
—
—
—
0
0
69
489
1.51
2.33
3.9
2.7
1.02
0.82
e6/l
0.24
36
234
22
113
2.01
2.31
1.4
1.6
—
—
—
0
0
296
2719
1.51
2.29
4.2
4.1
—
—
—
0
0
85
632
1.45
2.26
1.4
1.3
1.66
10.67
u/ml
4.29
34
242
16
73
2.25
2.24
2.5
2.9
3.80
2.44
index
—
10
41
104
805
1.41
2.22
4.7
2.8
0.19
0.31
e6/l
0.57
78
559
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
19
3.74
2.16
1.0
1.2
—
—
—
0
0
5
10
5.05
2.07
2.0
3.7
160.80
140.00
ug/l
—
5
10
7
20
3.55
2.06
1.0
1.1
1891.43
1487.80
miu/ml
—
7
20
303
2813
1.50
2.06
4.6
4.1
2.75
2.77
mmol/l
0.15
291
2693
22
121
1.87
1.93
1.9
1.4
—
—
—
0
0
58
414
1.48
1.89
2.6
2.3
3480.59
6070.06
u/l
0.40
18
180
283
2612
1.40
1.82
3.6
3.3
1.17
1.17
mmol/l
0.00
266
2475
18
95
1.94
1.78
1.5
1.2
—
—
—
0
0
299
2790
1.43
1.77
4.0
3.8
1.46
1.49
mmol/l
0.70
285
2667
12
54
2.26
1.76
11.6
5.0
64.25
61.09
%
0.25
12
54
6
18
3.37
1.75
2.7
1.5
—
—
—
0
0
300
2803
1.43
1.74
4.2
3.8
4.56
4.66
mmol/l
1.07
287
2691
7
24
2.95
1.73
1.1
1.4
74.29
74.67
%
—
7
24
7
24
2.95
1.73
1.1
1.4
531.00
389.12
mu/l
—
7
24
5
13
3.88
1.72
3.6
3.2
56.00
168.46
nmol/l
—
5
13
22
127
1.78
1.68
1.8
2.4
8.48
4.31
iu/l
—
10
56
6
19
3.19
1.67
2.7
3.1
1.37
2.08
nmol/l
—
6
19
10
41
2.48
1.65
1.9
1.5
—
—
—
0
0
18
98
1.88
1.65
2.9
1.5
435.75
337.57
mu/l
0.41
12
82
8
32
2.53
1.60
2.0
1.4
—
—
—
0
0
8
32
2.53
1.60
2.0
1.4
—
—
—
0
0
15
78
1.96
1.56
5.3
3.9
1.44
1.55
%
0.16
15
73
8
33
2.46
1.54
2.0
1.4
—
—
—
0
0
8
33
2.46
1.54
2.0
1.4
—
—
—
0
0
8
33
2.46
1.54
2.0
1.4
—
—
—
0
0
8
33
2.46
1.54
2.0
1.4
—
—
—
0
0
26
162
1.65
1.54
1.5
2.1
2.20
3.86
iu/ml
—
6
29
28
179
1.61
1.51
1.8
1.5
—
—
—
0
0
22
132
1.71
1.50
1.2
1.2
—
4.94
—
0
20
24
149
1.65
1.45
1.2
1.3
—
—
—
0
0
6
22
2.76
1.44
1.0
1.0
—
—
—
0
0
31
207
1.54
1.41
1.4
1.7
7.21
9.55
u/l
0.91
20
161
28
183
1.58
1.39
1.3
1.5
—
—
—
0
0
58
443
1.37
1.33
4.2
2.9
88.83
282.03
ng/l
1.32
30
237
40
287
1.44
1.30
3.0
3.6
33.03
31.22
%
0.56
31
202
13
69
1.92
1.30
2.2
2.1
—
—
—
0
0
117
991
1.27
1.29
4.4
2.6
0.08
0.01
estimate
0.38
40
305
18
284
0.61
1.21
1.6
1.7
—
—
—
0
0
29
200
1.49
1.16
3.5
1.9
0.20
0.13
e6/l
0.28
24
188
11
58
1.92
1.13
1.5
1.4
—
—
—
0
0
11
58
1.92
1.13
1.5
1.4
—
—
—
0
0
7
30
2.36
1.13
1.7
1.4
—
—
—
0
0
7
30
2.36
1.13
2.3
1.7
—
—
—
0
0
8
41
1.97
1.09
2.5
2.2
6.80
6.60
pmol/l
—
8
41
17
105
1.65
1.08
1.6
1.4
11.37
14.56
u/l
0.24
12
90
39
290
1.39
1.07
1.1
1.0
—
—
—
0
0
10
52
1.95
1.07
1.9
1.8
13.19
13.19
%
—
10
52
5
22
2.29
1.03
1.8
4.0
0.40
0.86
index
—
5
22
5
23
2.19
0.98
2.6
1.1
110.80
117.09
pmol/l
—
5
23
301
2887
1.27
0.88
21.2
14.4
332.60
332.98
g/l
0.32
301
2876
17
113
1.53
0.83
1.3
1.3
—
1.79
—
0
8
8
46
1.76
0.83
3.6
1.8
—
—
—
0
0
15
99
1.54
0.77
2.0
2.0
—
—
—
0
0
6
34
1.78
0.76
1.5
1.2
—
—
—
0
0
12
75
1.62
0.76
1.0
1.2
—
—
—
0
0
17
116
1.49
0.75
1.9
1.5
222.10
200.45
u/ml
—
10
66
98
861
1.19
0.74
1.9
1.5
—
—
—
0
0
49
593
0.80
0.74
1.6
1.6
1110.25
977.97
mu/l
0.33
39
512
25
186
1.37
0.72
1.4
1.4
—
—
—
0
0
14
93
1.53
0.70
1.3
1.4
315.78
317.29
ug/g
—
9
48
7
41
1.72
0.70
1.7
1.1
—
—
—
0
0
14
94
1.51
0.67
1.4
1.9
—
—
—
0
0
5
30
1.68
0.61
3.0
2.0
—
—
—
0
0
8
51
1.58
0.61
2.0
2.4
—
—
—
0
0
24
308
0.76
0.59
1.5
1.5
1.18
1.14
ratio
0.10
14
200
6
35
1.73
0.58
1.3
1.2
—
93.40
—
0
5
6
38
1.59
0.54
2.8
1.5
—
—
—
0
0
24
303
0.78
0.53
1.5
1.5
—
—
—
0
0
69
606
1.17
0.53
1.9
2.0
—
—
—
0
0
17
222
0.75
0.49
1.5
1.6
58.94
55.46
ug/l
0.15
17
222
7
46
1.53
0.48
1.3
1.5
—
—
—
0
0
7
46
1.53
0.48
1.0
1.6
—
—
—
0
0
25
308
0.80
0.47
1.5
1.5
1.16
0.94
ratio
0.55
15
200
25
308
0.80
0.47
1.5
1.5
1.22
1.21
ratio
0.03
15
200
17
129
1.33
0.46
1.5
1.5
0.39
0.42
nmol/l
0.08
12
111
7
50
1.41
0.45
1.3
1.5
—
—
—
0
0
5
31
1.62
0.43
2.0
2.1
1.43
0.75
e9/l
—
5
31
8
57
1.41
0.42
1.9
1.6
0.22
6.65
ug/l
—
8
51
15
114
1.33
0.41
20.3
8.8
1.23
1.16
mg/l
0.21
15
108
0
16
0.00
0.41
0.0
4.5
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
17
0.00
0.40
0.0
1.0
—
138.65
—
0
17
12
88
1.38
0.40
1.3
1.3
—
—
—
0
0
5
34
1.48
0.40
1.4
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
3.2
—
—
—
0
0
0
18
0.00
0.40
0.0
3.2
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
96.10
—
0
10
0
18
0.00
0.40
0.0
1.1
—
107.60
—
0
10
10
135
0.73
0.37
1.0
1.1
—
6.44
—
0
19
34
394
0.85
0.36
1.4
1.5
—
—
—
0
0
14
108
1.31
0.36
1.4
1.2
—
—
—
0
0
20
163
1.24
0.35
6.3
4.2
21.38
21.70
%
—
10
61
6
44
1.37
0.34
1.5
1.6
—
—
—
0
0
79
726
1.11
0.33
2.3
2.1
—
—
—
0
0
20
165
1.22
0.32
1.4
1.5
—
—
—
0
0
7
52
1.35
0.31
1.6
1.3
—
—
—
0
0
120
1134
1.09
0.29
1.7
1.8
1.26
1.31
mmol/l
0.27
106
1016
8
62
1.30
0.28
1.3
1.4
—
—
—
0
0
26
224
1.17
0.28
2.7
2.5
—
—
—
0
0
16
131
1.23
0.27
1.9
1.3
—
—
—
0
0
65
599
1.10
0.27
4.4
4.2
4.29
9.88
mg/mmol
1.13
41
382
18
150
1.21
0.27
1.2
1.2
0.85
0.87
g/l
0.08
18
150
5
38
1.32
0.23
3.0
1.8
—
—
—
0
0
5
39
1.29
0.23
1.2
1.6
—
—
—
0
0
22
252
0.86
0.22
2.1
1.8
—
—
—
0
0
13
107
1.22
0.22
1.4
1.2
—
—
—
0
0
13
156
0.83
0.21
2.2
2.0
—
—
—
0
0
5
42
1.19
0.21
1.4
2.6
6.06
7.11
u/ml
—
5
42
0
11
0.00
0.21
0.0
1.2
—
78.09
—
0
11
0
11
0.00
0.21
0.0
1.2
—
27.18
—
0
11
0
11
0.00
0.21
0.0
1.4
—
24.30
—
0
11
0
10
0.00
0.21
0.0
3.6
—
1.70
—
0
10
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.17
0.21
1.2
1.3
—
330.00
—
0
6
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
23
202
1.15
0.20
2.7
2.1
21.45
47.56
u/ml
1.24
23
193
0
14
0.00
0.20
0.0
1.4
—
3.50
—
0
14
20
174
1.16
0.20
1.5
1.4
0.07
0.27
mg/l
—
7
71
6
52
1.16
0.19
1.3
1.1
—
—
—
0
0
111
1065
1.06
0.18
2.8
2.5
—
—
—
0
0
42
453
0.92
0.17
1.9
1.7
3.48
3.31
ratio
0.49
30
337
10
82
1.23
0.17
3.7
1.6
—
—
—
0
0
9
79
1.14
0.15
3.0
1.6
—
—
—
0
0
14
159
0.88
0.13
1.7
4.2
1.86
6.12
ug/l
—
8
119
13
114
1.15
0.12
1.6
1.6
0.03
0.03
iu/ml
—
7
11
19
172
1.11
0.11
1.5
1.8
—
—
—
0
0
26
240
1.09
0.11
1.4
1.4
210.15
274.95
miu/ml
0.40
13
119
16
145
1.11
0.09
1.1
1.1
1.48
1.60
g/l
1.26
16
145
102
996
1.03
0.08
2.8
2.3
—
—
—
0
0
7
66
1.06
0.08
1.1
1.4
—
—
—
0
0
7
68
1.03
0.08
1.3
2.3
1.21
0.94
nmol/l
—
7
63
7
68
1.03
0.08
1.1
1.1
—
—
—
0
0
8
76
1.05
0.07
1.5
1.6
—
—
—
0
0
12
132
0.91
0.06
1.8
1.5
—
—
—
0
0
26
271
0.96
0.04
1.4
1.4
—
—
—
0
0
16
168
0.95
0.02
1.6
1.9
2.98
2.91
mg/l
0.02
11
113
36
351
1.03
0.02
1.6
1.6
3.52
3.41
mmol/l
0.20
22
243
16
166
0.96
0.00
1.4
1.5
—
—
—
0
0
18
183
0.98
0.00
4.5
2.8
57.71
80.51
ml/min/173m2
—
7
74
5
50
1.00
0.00
1.0
2.5
—
—
—
0
0
7
75
0.93
0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
4.31
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
7.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.2
—
11.72
—
0
9
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_ARNOLD_CHIARI_SYNDROME – Arnold-Chiari syndrome
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).